Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNovacyt Share News (NCYT)

Share Price Information for Novacyt (NCYT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 325.50
Bid: 325.50
Ask: 327.70
Change: -2.90 (-0.88%)
Spread: 2.20 (0.68%)
Open: 331.30
High: 331.40
Low: 325.50
Yest. Close: 328.40
NCYT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Novacyt appoints David Allmond as new chief executive

(Sharecast News) - Clinical diagnostics specialist Novacyt announced the appointment of David Allmond as its new chief executive officer and a member of its board on Thursday, effective from 18 October.

29 Jul 21 15:31

Novacyt launches two new rapid Covid-19 test products

(Sharecast News) - Clinical diagnostics specialist Novacyt announced the planned launch of two 'PathFlow' Covid-19 antigen lateral flow tests on Tuesday, to strengthen its Covid-19 portfolio and to pursue significant new market opportunities, particularly in point-of-care settings.

29 Jun 21 09:03

Novacyt swings to huge profit after pivot to Covid test portfolio

(Sharecast News) - Clinical diagnostics specialist Novacyt announced a more-than-twentyfold improvement in group consolidated revenue in its full-year results on Tuesday, to £277.2m, as its gross margin improved to 76.3% in 2020, from 64% in 2019.

22 Jun 21 08:46

Novacyt test for variants of concern included in NHS framework

(Sharecast News) - Clinical diagnostics company Novacyt announced on Monday that its 'SNPsig' SARS-CoV-2 polymerase chain reaction (PCR) genotyping portfolio has been included in the NHS England framework for detecting Covid-19 'variants of concern'.

17 May 21 09:16

Novacyt makes progress with Covid-19 programmes

(Sharecast News) - Clinical diagnostics specialist Novacyt updated the market on the progress of its near-term Covid-19 research and development programmes on Friday, addressing "rapidly-evolving" testing demands, particularly as SARS-CoV-2 continued to mutate globally.

23 Apr 21 16:28

Novacyt dispute with DHSC to dent 2021 profit, shares slide

(Sharecast News) - Novacyt said on Friday that a dispute with the Department of Health and Social Care (DHSC) over a supply contract could have a "material" impact on fourth-quarter revenues and dent 2021 profit and revenue, sending its shares sharply lower.

9 Apr 21 15:23

Novacyt launches CE-marked rapid Covid-19 variant test

(Sharecast News) - Clinical diagnostics specialist Novacyt announced the launch of 'SNPsig VariPLEX' on Wednesday, as a CE-marked polymerase chain reaction (PCR) assay panel, able to detect the four currently-recognised Covid-19 variants of concern, and the two most biologically significant mutations, in a single kit.

24 Mar 21 10:02

Novacyt launches mobile Covid-19 testing labs

(Sharecast News) - Clinical diagnostics specialist Novacyt announced the expansion of its 'VersaLab' service on Wednesday, with the launch of mobile processing laboratories to provide rapid turnaround polymerase chain reaction (PCR) testing on-site.

17 Mar 21 08:32

Covid-19 testing focus underpinning progress at Novacyt

(Sharecast News) - Clinical diagnostics company Novacyt updated the market on the progress of its near-term research and development programmes on Wednesday, including the expansion of its product portfolio, clinical trial activity and the publication of independent validations of its Covid-19 tests.

24 Feb 21 11:35

Novacyt launches new Covid-19 test assays for variant strains

(Sharecast News) - Clinical diagnostics company Novacyt announced the launch of a new portfolio of assays under the brand name 'SNPsig' on Tuesday, to aid the diagnosis of the new variants of SARS-CoV-2, the virus which causes the Covid-19 disease.

2 Feb 21 09:08

Novacyt FY revenues surge on demand for Covid-19 products

(Sharecast News) - Clinical diagnostics firm Novacyt said on Friday that full-year revenues had surged in 2020, driven by the continued successful global commercialisation of its Covid-19 product portfolio.

29 Jan 21 09:43

Novacyt taps James McCarthy as new CFO

(Sharecast News) - Clinical diagnostics company Novacyt announced on Tuesday that James McCarthy has been appointed as chief financial officer, while Anthony Dyer has taken on a new role as chief corporate development officer (CCDO).

5 Jan 21 10:53

Novacyt says its tests can detect new Covid strain, shares surge

(Sharecast News) - Novacyt shares surged on Monday after the clinical diagnostics specialist said that its tests can detect the new strain of Covid-19 identified by the UK's Genomics consortium, known as VUI-202012/01.

21 Dec 20 10:07

Novacyt releases new tests for Covid-19, bird flu

(Sharecast News) - Clinical diagnostics company Novacyt announced the launch of its research-use-only polymerase chain reaction test for a new strain of Covid-19 on Monday, as well as the development of two new research-use0only polymerase chain reaction tests for avian influenza, following recent outbreaks across Europe.

14 Dec 20 16:16

Novacyt swings to profit on soaring Covid test sales

(Sharecast News) - Covid-19 test maker Novacyt swung to a first-half profit driven by soaring sales during the current pandemic and said it expected core annual earnings to top €100m.

17 Sep 20 08:15

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.